Injectable and topical neurotoxins in dermatology : Basic science, anatomy, and therapeutic agents - 14/12/17
Abstract |
Botulinum toxin is a potentially deadly anaerobic bacterial toxin that acts by inhibiting release of acetylcholine at the neuromuscular junction, thereby inhibiting contraction of the exposed striated muscle. There are currently 4 botulinum toxin preparations approved by the US Food and Drug Administration (FDA): onabotulinumtoxin, abobotulinumtoxin, incobotulinumtoxin and rimabotulinumtoxin. While significant overlap exists, each product has unique properties and specifications, including dosing, diffusion, and storage. Extensive physician knowledge of facial anatomy, coupled with key differences of the various neurotoxin types, is essential for safe and successful treatments. The first article in this continuing medical education series reviews key characteristics of each neurotoxin, including new and upcoming agents, and provides an anatomic overview of the most commonly injected cosmetic sites.
Le texte complet de cet article est disponible en PDF.Key words : abobotulinum, anatomy, botulinum toxin, Clostridium botulinum, incobotulinum, lower face, neuromodulator, neurotoxin, new indications, onabotulinum, properties, rimabotulinum, RT001, RT002, upper face
Plan
Funding sources: None. |
|
Conflicts of interest: None declared. |
|
Reprints not available from the authors. |
|
Date of release: June 2017 |
|
Expiration date: June 2020 |
Vol 76 - N° 6
P. 1013-1024 - juin 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?